Arbutus Biopharma Corp

ABUSNASDAQ
$4.85
-0.03-0.61%
À la clôture: Sep 25, 5:00 PM EST
$4.86
0.01010.21%
Après les heures: 7:57 PM EST

Arbutus Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Arbutus Biopharma (ABUS).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

1S.Buy
3Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$6Upside to Avg. PT+13.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Nov 14, 2025Chardan CapitalKeay NakaeMaintainedBuy$5
Aug 11, 2025Chardan CapitalKeay NakaeMaintainedBuy$5